Atomera (ATOM) Competitors $5.08 +0.11 (+2.21%) Closing price 10/15/2025 04:00 PM EasternExtended Trading$5.11 +0.03 (+0.59%) As of 05:26 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ATOM vs. AIP, IPAX, CLFD, VREX, CAN, MVIS, NNDM, SATL, LPTH, and DVLTShould you be buying Atomera stock or one of its competitors? The main competitors of Atomera include Arteris (AIP), Inflection Point Acquisition (IPAX), Clearfield (CLFD), Varex Imaging (VREX), Canaan (CAN), Microvision (MVIS), Nano Dimension (NNDM), Satellogic (SATL), LightPath Technologies (LPTH), and Datavault AI (DVLT). These companies are all part of the "electronic equipment" industry. Atomera vs. Its Competitors Arteris Inflection Point Acquisition Clearfield Varex Imaging Canaan Microvision Nano Dimension Satellogic LightPath Technologies Datavault AI Arteris (NASDAQ:AIP) and Atomera (NASDAQ:ATOM) are both small-cap computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, media sentiment, analyst recommendations, institutional ownership, earnings and dividends. Does the media prefer AIP or ATOM? In the previous week, Arteris had 11 more articles in the media than Atomera. MarketBeat recorded 14 mentions for Arteris and 3 mentions for Atomera. Atomera's average media sentiment score of 0.70 beat Arteris' score of 0.37 indicating that Atomera is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Arteris 8 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Atomera 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend AIP or ATOM? Arteris currently has a consensus target price of $15.00, suggesting a potential upside of 4.09%. Given Arteris' stronger consensus rating and higher probable upside, equities research analysts plainly believe Arteris is more favorable than Atomera.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Arteris 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50Atomera 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Is AIP or ATOM more profitable? Arteris has a net margin of -52.41% compared to Atomera's net margin of -15,555.37%. Atomera's return on equity of -90.84% beat Arteris' return on equity.Company Net Margins Return on Equity Return on Assets Arteris-52.41% -8,546.17% -31.56% Atomera -15,555.37%-90.84%-78.02% Which has more volatility and risk, AIP or ATOM? Arteris has a beta of 1.45, indicating that its share price is 45% more volatile than the S&P 500. Comparatively, Atomera has a beta of 1.13, indicating that its share price is 13% more volatile than the S&P 500. Which has preferable earnings & valuation, AIP or ATOM? Atomera has lower revenue, but higher earnings than Arteris. Arteris is trading at a lower price-to-earnings ratio than Atomera, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioArteris$57.72M10.65-$33.64M-$0.82-17.57Atomera$49K3,263.95-$18.43M-$0.67-7.58 Do institutionals & insiders have more ownership in AIP or ATOM? 64.4% of Arteris shares are held by institutional investors. Comparatively, 30.8% of Atomera shares are held by institutional investors. 29.1% of Arteris shares are held by company insiders. Comparatively, 13.0% of Atomera shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. SummaryArteris beats Atomera on 10 of the 16 factors compared between the two stocks. Get Atomera News Delivered to You Automatically Sign up to receive the latest news and ratings for ATOM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ATOM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ATOM vs. The Competition Export to ExcelMetricAtomeraELEC COMP IndustryComputer SectorNASDAQ ExchangeMarket Cap$156.47M$46.19B$32.38B$10.45BDividend YieldN/A2.09%3.20%4.77%P/E Ratio-7.58712.76494.8327.36Price / Sales3,263.95410.951,520.80137.65Price / CashN/A103.8637.7961.86Price / Book5.846.737.766.81Net Income-$18.43M$551.26M$820.59M$276.80M7 Day Performance9.96%3.48%0.18%0.42%1 Month Performance46.82%32.68%6.50%7.86%1 Year Performance40.33%73.53%23,961.12%41.24% Atomera Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ATOMAtomera0.2582 of 5 stars$5.08+2.2%N/A+48.5%$156.47M$49K-7.5820AIPArteris1.6645 of 5 stars$12.39-5.5%$15.00+21.1%+96.3%$528.43M$57.72M-15.11240Gap UpIPAXInflection Point AcquisitionN/A$12.23-4.0%N/A+77.1%$504.11MN/A0.001Gap DownHigh Trading VolumeCLFDClearfield2.5076 of 5 stars$34.84-5.3%$47.50+36.3%+2.5%$481.00M$179.32M3,484.001,130VREXVarex Imaging4.3793 of 5 stars$10.81-4.3%$19.50+80.4%+2.9%$448.62M$821.40M-3.372,300CANCanaan3.2225 of 5 stars$1.09-11.1%$2.54+134.3%+102.1%$404.60M$269.32M-1.21350Trending NewsAnalyst ForecastOptions VolumeGap UpMVISMicrovision1.7437 of 5 stars$1.26-7.4%$2.50+98.4%+15.8%$379.21M$4.70M-3.23350NNDMNano Dimension0.7674 of 5 stars$1.66-6.0%N/A-14.0%$361.39M$69.66M-1.61340SATLSatellogicN/A$3.39-15.9%N/A+320.7%$357.88M$12.87M0.00330LPTHLightPath Technologies1.4949 of 5 stars$7.97-17.0%$6.50-18.4%+505.0%$356.02M$37.20M-22.14330Gap UpDVLTDatavault AI2.4261 of 5 stars$1.90-16.7%$7.00+268.4%N/A$326.50M$2.67M0.0040Gap Up Related Companies and Tools Related Companies Arteris Competitors Inflection Point Acquisition Competitors Clearfield Competitors Varex Imaging Competitors Canaan Competitors Microvision Competitors Nano Dimension Competitors Satellogic Competitors LightPath Technologies Competitors Datavault AI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ATOM) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersOptions Pro Reveals His #1 Retirement Income TradeIf you can be at your computer between 9 a.m. and 10:45 a.m. on most weekdays, I’ll show you a simple trading ...Base Camp Trading | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredBuy this stock before Tesla’s November 6 announcementThe End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atomera Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Atomera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
